Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2554)	6/2/2010 2:09:43 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NPS was up 8.63% and is still up 7.89% at present, with volume of > 414Ks almost at its ADV.<g> But it still trading below the resistance at the $7 level. bigcharts.marketwatch.com It was initiated today by Think Equity with a "buy" rating.<g> Next week it will be presenting at the 9th Annual Needham Healthcare Conference in N.Y. on Wednesday and the Jefferies 2010 Global Life Sciences Conference also in N.Y. on Friday. NPS had a pretty good report on its 1stQ with revenues up 24% and trimming its loss from $0,22 to $0.06 However, the EL for 2010 is still around $0.65 vs. $0.37 in 2009 It is trying to develop new treatments for patients with rare gastrointestinal and some endocrine disorders.<g> It has two PIIIs going on. Its Teduglutide is an analog of GLP-2, and is on a PII for intestinal failure associated with short bowel syndrome and is also in preclinical development for chemotherapy-induced gastrointestinal mucositis. Its parathyroid hormone 1-84 injection) is also on a PIII as a hormone replacement therapy for hypoparathyroidism. The ACTAY is $9.36 It has had a good performance this Yr. from the start of the UT on Feb23 bigcharts.marketwatch.com It seems that with some good news the stock could get to the $10 level.< g> bigcharts.marketwatch.com But is probably better to wait for it to close above $7 and then to keep a close trailing stop loss.<g> Bernard